Marker Therapeutics Inc
NASDAQ:MRKR

Watchlist Manager
Marker Therapeutics Inc Logo
Marker Therapeutics Inc
NASDAQ:MRKR
Watchlist
Price: 3.8 USD 1.88% Market Closed
Market Cap: 33.9m USD
Have any thoughts about
Marker Therapeutics Inc?
Write Note

Intrinsic Value

MRKR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MRKR stock under the Base Case scenario is 3.84 USD. Compared to the current market price of 3.8 USD, Marker Therapeutics Inc is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRKR Intrinsic Value
3.84 USD
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Marker Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for MRKR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MRKR?
Bearish
Neutral
Bullish

Fundamental Analysis

3.8 USD
+1.88%
+1.88%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Marker Therapeutics Inc
US
Biotechnology
Market Cap
33.8m USD
IPO
Nov 8, 2016
Employees
56
United States of America
Market Cap
33.8m USD
Industry
Biotechnology
IPO
Nov 8, 2016
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Marker Therapeutics Inc

Provide an overview of the primary business activities
of Marker Therapeutics Inc.

What unique competitive advantages
does Marker Therapeutics Inc hold over its rivals?

What risks and challenges
does Marker Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Marker Therapeutics Inc recently?

Summarize the latest earnings call
of Marker Therapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Marker Therapeutics Inc.

Provide P/S
for Marker Therapeutics Inc.

Provide P/E
for Marker Therapeutics Inc.

Provide P/OCF
for Marker Therapeutics Inc.

Provide P/FCFE
for Marker Therapeutics Inc.

Provide P/B
for Marker Therapeutics Inc.

Provide EV/S
for Marker Therapeutics Inc.

Provide EV/GP
for Marker Therapeutics Inc.

Provide EV/EBITDA
for Marker Therapeutics Inc.

Provide EV/EBIT
for Marker Therapeutics Inc.

Provide EV/OCF
for Marker Therapeutics Inc.

Provide EV/FCFF
for Marker Therapeutics Inc.

Provide EV/IC
for Marker Therapeutics Inc.

Show me price targets
for Marker Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Marker Therapeutics Inc?

How accurate were the past Revenue estimates
for Marker Therapeutics Inc?

What are the Net Income projections
for Marker Therapeutics Inc?

How accurate were the past Net Income estimates
for Marker Therapeutics Inc?

What are the EPS projections
for Marker Therapeutics Inc?

How accurate were the past EPS estimates
for Marker Therapeutics Inc?

What are the EBIT projections
for Marker Therapeutics Inc?

How accurate were the past EBIT estimates
for Marker Therapeutics Inc?

Compare the revenue forecasts
for Marker Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Marker Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Marker Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Marker Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Marker Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Marker Therapeutics Inc with its peers.

Analyze the financial leverage
of Marker Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Marker Therapeutics Inc.

Provide ROE
for Marker Therapeutics Inc.

Provide ROA
for Marker Therapeutics Inc.

Provide ROIC
for Marker Therapeutics Inc.

Provide ROCE
for Marker Therapeutics Inc.

Provide Gross Margin
for Marker Therapeutics Inc.

Provide Operating Margin
for Marker Therapeutics Inc.

Provide Net Margin
for Marker Therapeutics Inc.

Provide FCF Margin
for Marker Therapeutics Inc.

Show all solvency ratios
for Marker Therapeutics Inc.

Provide D/E Ratio
for Marker Therapeutics Inc.

Provide D/A Ratio
for Marker Therapeutics Inc.

Provide Interest Coverage Ratio
for Marker Therapeutics Inc.

Provide Altman Z-Score Ratio
for Marker Therapeutics Inc.

Provide Quick Ratio
for Marker Therapeutics Inc.

Provide Current Ratio
for Marker Therapeutics Inc.

Provide Cash Ratio
for Marker Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Marker Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Marker Therapeutics Inc?

What is the current Free Cash Flow
of Marker Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Marker Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Marker Therapeutics Inc

Current Assets 10.9m
Cash & Short-Term Investments 9m
Receivables 744.4k
Other Current Assets 1.2m
Current Liabilities 3.5m
Accounts Payable 2.6m
Other Current Liabilities 903.4k
Efficiency

Earnings Waterfall
Marker Therapeutics Inc

Revenue
5.4m USD
Operating Expenses
-15.6m USD
Operating Income
-10.2m USD
Other Expenses
498k USD
Net Income
-9.7m USD

Free Cash Flow Analysis
Marker Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MRKR Profitability Score
Profitability Due Diligence

Marker Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

31/100
Profitability
Score

Marker Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

MRKR Solvency Score
Solvency Due Diligence

Marker Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Marker Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRKR Price Targets Summary
Marker Therapeutics Inc

Wall Street analysts forecast MRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRKR is 16.07 USD with a low forecast of 12.63 USD and a high forecast of 19.95 USD.

Lowest
Price Target
12.63 USD
232% Upside
Average
Price Target
16.07 USD
323% Upside
Highest
Price Target
19.95 USD
425% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MRKR?

Click here to dive deeper.

Dividends

Marker Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MRKR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MRKR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MRKR stock?

The intrinsic value of one MRKR stock under the Base Case scenario is 3.84 USD.

Is MRKR stock undervalued or overvalued?

Compared to the current market price of 3.8 USD, Marker Therapeutics Inc is Undervalued by 1%.

Back to Top